Over the past several months, the use of MDMA as a treatment for Post Traumatic Stress Disorder (PTSD) has circulated through the medical community.

Now, despite the controversial nature of such a proposal, MDMA may be on its way to gain Food & Drug Administration (FDA) approval for its medicinal qualities. For those who may not now, MDMA is the active ingredient in ecstasy and, in its purest form, has a history of psychoanalytic use.

So far, the Multidisciplinary Association for Psychedelic Studies (MAPS) has been conducting studies using MDMA, specific to PTSD treatment, and are about to conclude the second phase of their research on the treatment. Thus far, though, the results have been heavily in favor of the psychoanalytic benefits of the drug, with 83% of subjects showing no signs of PTSD two months after treatment and, after 4 years, most of the results sticking.

Though admittedly a small study with a small sample size (20 subjects), the results were enough for MAPS to go ahead with the second phase of the required three human trials when drugs seek FDA approval. Now, this second phase is set to come to an end, with over 125 people subjected to 8 individual tests.

Results and data have not been published, but MAPS has already been seeking with the FDA regarding a third phase, where hundreds of subjects would be given the treatment, with Brad Burge, the director of communications for MAPS, confidently proclaiming how he see’s MDMA being medicinally legal by 2021.

With phase 3 beginning in 2017 and expected to take 5 years to complete, the medicinal legalization is still a ways away but, for the epidemic that it PTSD in the US and abroad, specifically from returning veterans of the Iraq and Afghanistan wars, the news cannot come soon enough. In fact, Iraq veteran Tony Macie, who had been a subject in the drug’s early trial stages has said: “I reconnected with myself and did a lot of internal work, and afterwards it was like a huge weight was lifted off my shoulders.”

You can watch Macie’s full video statement on his battle with PTSD and the effects of MDMA below.

Source: Business Insider